Efficacy and safety of ASK120067 (limertinib) in patients with locally advanced or metastatic EGFR T790M-mutated non–small cell lung cancer: A multicenter, single-arm, phase IIb study.

Baolan Li, Yuankai Shi, Yueyin Pan et al.|Journal of Clinical Oncology|2022

Cited by 3